Hemp oil does have a number of uses and is often marketed as a cooking oil or a product that is good for moisturizing the skin. It is also used in the production of certain soaps, shampoos, and foods. It is also a basic ingredient for bio-fuel and even a more sustainable form of plastic. Hemp has been cultivated and used for roughly 10,000 years, and it definitely has useful purposes. However, a lack of cannabinoids, namely CBD, means that it has little therapeutic value.
CBD interacts with the body’s endocannabinoid system; this system exists to keep our bodies in balance. Most of the time when someone is overweight there is one main culprit that leads to them struggling with weight loss: metabolism. Metabolism and weight loss are very connected because your metabolism is what converts food into energy in the body. It’s also responsible for the body’s ability to burn calories and the rate at which it does so.
In addition to their range of oral CBD tinctures (which are administered via droplets placed below the tongue), Aura CBD also offers a newly-introduced Turmeric MCT cannabis butter (which is great to use in tea, coffee, smoothies, or as a cooking oil), a variety of CBD skincare products, and a delicious range of CBD edibles including our personal favorite raw CBD chocolates, which contain organic cacao powder and raw, organic agave.
Pure Hemp Botanicals has created a soothing tea made from whole-plant ingredients. The product is packaged locally and is cruelty-free and vegan. It includes the flavors of hibiscus and apple to reduce the hemp aftertaste. The hemp used to create this oil has been organically grown, and the tea contains full-spectrum plant terpenes that are entirely natural. It is also caffeine free.
Aura CBD oil actually comes from a well-known and respected brand based in California, but it has a strong presence in the UK with a London office, and currently ships to residential addresses throughout the United Kingdom. Over the last year or so the brand has taken big steps to cement their presence on the UK CBD market, and is now offering high-potency hemp pastes, CBD edibles, and CBD skincare products in addition to their range of top-class CBD tinctures.
To make matters more confusing, nine states (including California, Washington, and Colorado) let residents buy cannabis-based products with or without THC. Nearly two dozen other “medical marijuana states” allow the sale of cannabis, including capsules, tinctures, and other items containing CBD or THC, at licensed dispensaries to people whose doctors have certified that they have an approved condition (the list varies by state but includes chronic pain, PTSD, cancer, autism, Crohn’s disease, and multiple sclerosis). Sixteen more states legalized CBD for certain diseases.

This study combats the notion that CBD causes a THC high by discussing the misinterpretations of prior studies on the subject. In fact, the researchers state that two particular prior studies “have caused much confusion and uncertainty whether oral cannabidiol (CBD) is safe and whether subjects who are treated with CBD run the risk of positive workplace tests [for THC].”


Because PharmaHemp’s first business is that of a supplier of raw materials, many of the micro brands you may have come across in Europe and beyond maybe white-labelling PharmaHemp’s CBD oil; in other words, they put their own stamp (branding and packaging) on PharmaHemp’s formulas or requested bespoke formulas. Why not just take it directly from the source? We like dealing with the main supplier directly, particularly in the case of PharmaHemp, who already has a very strong brand identity and ethos. We match their prices and import their products regularly to have the freshest batches of their stock available. Visit the PharmaHemp collection.
John Staughton is a traveling writer, editor, and publisher who earned his English and Integrative Biology degrees from the University of Illinois in Champaign, Urbana (USA). He is the co-founder of a literary journal, Sheriff Nottingham, and calls the most beautiful places in the world his office. On a perpetual journey towards the idea of home, he uses words to educate, inspire, uplift and evolve.
CBD’s effect on homeostasis is believed to be why those in need of nutrition can experience an appetite increase and those with excess weight can experience an appetite decrease. The reason for this is that CBD is an adaptogen. Referred to by some scientists as “the boy scout molecule” because it always does the right thing in any given situation. The Journal of  Psychopharmacology tested this theory on rats in 2012. The researchers wanted to see how three common cannabinoids, including CBN, CBD, and CBG, affected the appetite of the rats. The study concluded that both CBD and CBG worked to reduce the rat’s appetite.
In addition to acting on the brain, CBD influences many body processes. That’s due to the endocannabinoid system (ECS), which was discovered in the 1990s, after scientists started investigating why pot produces a high. Although much less well-known than the cardiovascular, reproductive, and respiratory systems, the ECS is critical. “The ECS helps us eat, sleep, relax, forget what we don’t need to remember, and protect our bodies from harm,” Marcu says. There are more ECS receptors in the brain than there are for opioids or serotonin, plus others in the intestines, liver, pancreas, ovaries, bone cells, and elsewhere.

Even though high-strength CBD oils are more expensive than lower concentrates, they work out to be more cost-effective and longer-lasting because you’ll need fewer drops to obtain the same effect. For example, a single drop of Love Hemp’s 40% CBD oil contains 20mg of CBD, that is 4 times more than a 10% tincture, which provides just 5mg per drop. If you’re looking to take a high dose, stronger concentrates will also make it easier to achieve your desired dose (fewer drops to count!).


Over the past few years, increasing public and political pressure has supported legalization of medical marijuana. One of the main thrusts in this effort has related to the treatment of refractory epilepsy—especially in children with Dravet syndrome—using cannabidiol (CBD). Despite initiatives in numerous states to at least legalize possession of CBD oil for treating epilepsy, little published evidence is available to prove or disprove the efficacy and safety of CBD in patients with epilepsy. This review highlights some of the basic science theory behind the use of CBD, summarizes published data on clinical use of CBD for epilepsy, and highlights issues related to the use of currently available CBD products.
Authors: Leinwand, Kristina L. DO; Gerich, Mark E. MD; Hoffenberg, Edward J. MD; Collins, Colm B. PhD; National Institutes of Health T32 Institutional Training Grant in Pediatric Gastroenterology; National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health; Colorado Department of Public Health and Environment
Furthermore, a study published in the Journal of Neuroendocrinology has suggested that the ECS is capable of stimulating specific areas of the body involved in metabolism, such as the skeletal muscles and GI tract. This happens due to the presence of anandamide and 2-AG, which are two naturally-occurring compounds in the body that interact with the CB1 and CB2 receptors.
When the founders of Love CBD, Phil and Dan Culbertson, saw the success of CBD oil in the USA, they saw an opportunity for launching a CBD business in the UK. This family-run business from Newmarket, Suffolk, realised that many of the CBD oils available in the UK at that time (in 2014) were of substandard quality and decided to become CBD connoisseurs and put together blends with what they considered to be the best hemp strains out there.
Lisa Hamilton, a jeweler and doula in Brooklyn, NY, knows about the side effects. She recently tried CBD for the shoulder pain that plagued her five years after an accident. Her doctor certified that she was in chronic pain, which under New York State law allowed her to buy from a state dispensary. One Friday, she swallowed two 10-mg capsules, the amount recommended at the dispensary, then took another two on Saturday. “By Sunday, it felt like I’d gotten hit by a truck. Every muscle and joint ached,” Hamilton says. She cut back to one pill a day the following week, but still felt hungover. She stopped after that.
CBD is well tolerated in humans with doses up to 600 mg not resulting in psychotic symptoms (15). In the few small placebo-controlled studies performed, no significant CNS effects were noted. Oral CBD undergoes extensive first-pass metabolism via CYP3A4, with a bioavailability of 6%. Following single doses in humans, the half-life of CBD when taken orally is about 1 to 2 days.1 In vitro studies have shown that CBD is a potent inhibitor of multiple CYP isozymes, including CYP 2C and CYP3A (16, 17). Whether these in vitro observations are relevant at plasma concentrations likely to be seen in patients is unclear. In addition, given its metabolism via CYP3A4, clinical trials of CBD in patients receiving enzyme-inducing AEDs, such as carbamazepine or phenytoin, will require detailed pharmacokinetic studies.
In addition to acting on the brain, CBD influences many body processes. That’s due to the endocannabinoid system (ECS), which was discovered in the 1990s, after scientists started investigating why pot produces a high. Although much less well-known than the cardiovascular, reproductive, and respiratory systems, the ECS is critical. “The ECS helps us eat, sleep, relax, forget what we don’t need to remember, and protect our bodies from harm,” Marcu says. There are more ECS receptors in the brain than there are for opioids or serotonin, plus others in the intestines, liver, pancreas, ovaries, bone cells, and elsewhere.
If you think you may have a medical emergency, call your healthcare provider or 911 immediately. Any mention of products or services is not meant as a guarantee, endorsement, or recommendation of the products, services, or companies. Reliance on any information provided is solely at your own risk. Please discuss any options with your healthcare provider.
CBD is well tolerated in humans with doses up to 600 mg not resulting in psychotic symptoms (15). In the few small placebo-controlled studies performed, no significant CNS effects were noted. Oral CBD undergoes extensive first-pass metabolism via CYP3A4, with a bioavailability of 6%. Following single doses in humans, the half-life of CBD when taken orally is about 1 to 2 days.1 In vitro studies have shown that CBD is a potent inhibitor of multiple CYP isozymes, including CYP 2C and CYP3A (16, 17). Whether these in vitro observations are relevant at plasma concentrations likely to be seen in patients is unclear. In addition, given its metabolism via CYP3A4, clinical trials of CBD in patients receiving enzyme-inducing AEDs, such as carbamazepine or phenytoin, will require detailed pharmacokinetic studies.
BioBloom Hemp believes that their range of drops, 4%, 6% and 8% extracts, are all you need. Not only if you’re getting started with CBD oil, but also if you’re looking to take a high-strength concentrate. How can you accomplish a 40% effect (the strongest available) with a 4% concentrate? You would just need to take more of it; so, instead of taking 1 drop of a 40% CBD, you take 10 drops of BioBloom’s 4% CBD drops. The CBD content is the same, but BioBloom says that this equivalence comes with an added benefit: you get more of the full-spectrum cannabinoid profile. In other words, by taking more of the oil, you take in more cannabinoids, thus enhancing the effect of the main active ingredient.
The increased activity of the pancreas in an attempt to secrete additional insulin can cause inflammation throughout the gland. That chronic inflammation can actually destroy the beta cells which are the sites that secrete insulin. This downward spiral diminishes the body’s ability to make insulin at all – a dangerous path that can lead to diabetes.
CBD has been touted for a wide variety of health issues, but the strongest scientific evidence is for its effectiveness in treating some of the cruelest childhood epilepsy syndromes, such as Dravet syndrome and Lennox-Gastaut syndrome (LGS), which typically don’t respond to antiseizure medications. In numerous studies, CBD was able to reduce the number of seizures, and in some cases it was able to stop them altogether. Videos of the effects of CBD on these children and their seizures are readily available on the Internet for viewing, and they are quite striking. Recently the FDA approved the first ever cannabis-derived medicine for these conditions, Epidiolex, which contains CBD.
CBD is well tolerated in humans with doses up to 600 mg not resulting in psychotic symptoms (15). In the few small placebo-controlled studies performed, no significant CNS effects were noted. Oral CBD undergoes extensive first-pass metabolism via CYP3A4, with a bioavailability of 6%. Following single doses in humans, the half-life of CBD when taken orally is about 1 to 2 days.1 In vitro studies have shown that CBD is a potent inhibitor of multiple CYP isozymes, including CYP 2C and CYP3A (16, 17). Whether these in vitro observations are relevant at plasma concentrations likely to be seen in patients is unclear. In addition, given its metabolism via CYP3A4, clinical trials of CBD in patients receiving enzyme-inducing AEDs, such as carbamazepine or phenytoin, will require detailed pharmacokinetic studies.
The major problem with CBD bottles on the open market is that in most cases they will contain levels of THC which are higher than the amount legally allowed to sell. This means that in most states (with only a few exceptions such as California, Colorado and Oregon), THC is currently legally available only as Medical Cannabis, and should be sold only by legit dispensaries that have received proper licensing from the state.
×